Although AT-RvD1 significantly reduced cardiomyocyte cross-sectional area, the effect was blunted by the absence of FPR2 because in the FPR2-/- mice, there was no reduction in cardiac hypertrophy (Fig 5B). The gene discussed is FPR2; the disease is cardiac hypertrophy.